The American Advisory Committee on Immunization Practices (ACIP) met recently, voting to change MMRV and COVID-19 vaccine guidelines and recommendations, and postponing a vote on proposed changes to hepatitis B vaccination.
The combination measles, mumps, rubella and varicella vaccine (MMRV) is no longer recommended in the US for children under 4 years of age. The COVID-19 vaccine is no longer recommended for all adults in the US; recommendations are now subject to a ‘shared decision-making’ process whereby individuals are advised to weigh up risks and benefits with a healthcare professional.
Via our social media platforms, MVEC has published a shortform explainer (@mvecau on Instagram) on ACIP’s MMRV change and why it shouldn’t impact confidence in Australia’s immunisation program.
Materials from the 18 to 19 September meeting 是 not yet fully accessible for all audiences.
The following articles from US-based publications offer more context on the ACIP meeting:
NPR: CDC advisers punt on hepatitis B vaccine vote, after changing guidance on MMRV
ABC News: Why doctors say the birth dose of the hepatitis B vaccine is still necessary
For more information on the relevant vaccine-preventable diseases, go to:
MVEC：麻疹
MVEC: Varicella
MVEC：COVID-19
MVEC：乙型肝炎